Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
80 hedge funds and large institutions have $357M invested in Taro Pharmaceutical Industries Ltd. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
3% less capital invested
Capital invested by funds: $369M → $357M (-$11.7M)
5% less funds holding
Funds holding: 84 → 80 (-4)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.84M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.84M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.04M |
| 3 |
BlackRock
New York
|
+$2.68M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.78M |
| 5 |
JP Morgan Chase
New York
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$7.58M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.16M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$3.34M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$2.83M |
| 5 |
Renaissance Technologies
New York
|
-$2.43M |
TARO Hedge Fund Activity: Q1 2021 in Review
80 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2021, worth a combined $357M — down 3.2% from $369M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TARO and 10 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 24 added.
The largest buyer was ARK Investment Management, adding an estimated $3.84M. The largest seller was Northern Trust, cutting an estimated $7.58M.
- 80 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2021, down from 84 in Q4 2020.
- Funds reported $357M of Taro Pharmaceutical Industries Ltd. stock for Q1 2021, down 3.2% quarter-over-quarter.
- 10 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2021 and 13 closed out, a net change of -3 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2021 was ARK Investment Management, an estimated $3.84M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2021 was Northern Trust, an estimated $7.58M sold.
Based on aggregated 13F filings for Q1 2021.